药理考试题09中枢提纲_第1页
药理考试题09中枢提纲_第2页
药理考试题09中枢提纲_第3页
药理考试题09中枢提纲_第4页
药理考试题09中枢提纲_第5页
已阅读5页,还剩19页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

药理ZCentralnervousdepressantsCycleofSleep

CHAPTERREM(rapideyemovementsleep),24%ofthetotalsleep,aboutlasts20min.NREM(non-rapideyemovementsleep),70%-75%oftotalsleep,about80-120min.Stage1“descending”sleep,dozinganddrowsiness.Stage2unequivocalmajorfraction,50%ofsleep.Stage3deepsleeptransition.Stage4“cerebral”sleepslowwovesleep,somnambulismandInman,thephysiologicalsleepconsistsof4-5cyclesofalternativeREMandNREMsleep.SpecificityofSedative-hypnoticdrugsGradeddose-dependentdepressionofCNSfunctionTypeA sedationhypnosisanaesthesiacomaparalysisfailure.TypeB sedationhypnosisanaesthesia.metabolictolerance(enzymeinducer)pharmacodynamictolerancePsychologicaldependencePhysiologicaldependence

Section1 diazepam(,安定)ClassificationsofBZsShort-acting(t1/2<6hrs):triazolam2.3±0.4Intermediate-acting(t1/2=6-20hrs):lorazepam,oxazepam,clonazepam.Long-acting(t1/2>20hrs):diazepam,chlordiazepoxide,flurazepam.PharmacologicalEffectsandAntianxietysmallAnxiety:nervous,anxious,Sedationandprolongphse2sleep,shortenphase4sleep,littleinfluencesonREM,littlerebound.Usedinthetreatmentofnsomniaandamnesia(短暂性缺失)Advantagesofhighertherapeuticindex,noanaesthesiainlargelowafter↓thedurationofslow-wave littleinfluencesondonotinducehepaticdependenceisAnticonvulsanteffectandantiepilepticCentralmusclerelaxation.MechanismsofactionIncreasetheefficiencyofGABA-ergicinhibition.EnhanceRaffinityforGABA.IncreasethefrequencyofCLchannelopening.NotsubstituteforGABA.Theratesoforalabsorption,Cmaxabout1hour:rapidtriazolam.Lipidsolubilityysamajorrole,centalbarrier/breastmilk.highsmaproteinbinding.AdverseDrugCNSdepression:drowsiness,fatigure,dizziness,motorincoordination.inhibitionofrespirationandcardiovascularfunction.ToleranceandDependenceTheonlyantagonist

UsefordiagnosisandtherapyofBZAshorthalflife,sorequiringrepeatedadministrationCauseabstinenceseizuresSection2PharmacokineticsAbsorbedeasilyfollowingpoandimMetaboliteslackDrugswithhighlipophilicity:livermetabolism.Drugswithlowlipophilicity:kidneyexcretion.Phenobarbitalintoxication:alkalinizationoftheurine.↑GABAergicinhibition(durationofchannelopening↑),GABAmimetic(highdose),inhibitexicitatoryneurotransmitter.SedationandhypnosisAnticonvulsantAnesthesisandadministrationpre-anesthesisthiopental(硫喷妥)EnhancetheeffectsofotherCNSdepressants.AdversedrugAfterToleranceanddependenceInhibitionofrespirationfunctionAllergicreactionHepaticenzymeSection3Chloralhydrate(水合氯醛)Hypnosisandanticonvulsanteffects.IrritationtomucousmembraneInhibitcardiacClinicalusesofsedative-ReliefofSedationandamnesiabeforemedicalandsurgicalTreatmentofepilepsyandseizureAsacomponentofbalancedanesthesia(intravenousForcontrolofethanolorothersedative-hypnoticwithdrawalFormusclerelaxationinspecificneuromuscularAsdiagnosticaidsorfortreatmentinCentralStimulantsCorticalstimulants(皮层兴奋药):Caffeine(、Methylphenidate(哌甲酯)stimulants(:、Lobeline(stimulants(:strychnine(Caffeine(PharmacologicalEffectsCNSeffectsPeripheraleffectsCardiacstimulationSmoothmusclerelaxation.MechanismsofActionAC,intracellularcAMPandantagonismofadenosine.CNSMigrainewithergotamineHeadachewithaspirinAdverseReaction

Methylphenidate(Ritalin,哌甲酯,CNSstimulationweaker,psychoticMechanismmayberelatedtoincreaseofNE,DA,5-HTrelease.CNSdepressionEnuresisinHyperkineticsyndromeinNikethamide(Stimulatestherespiratorycenterinmeddula.Activatescarotidbodyandaorticarchchemoceptors.IncreasethesensitivityofrespiratorycentertopCO2.Centralrespiratoryfailure,acutecentraldepressantsintoxication,morphineinducedrespiratorydepression,acuterespiratoryinsufficiencyinpatientswithchronicobstractivepulmonarydiseases.Dimefline(二甲Stimulatetherespiratorycenter.BlockGABA-RActivatescarotid

Lobeline(Uses:newbornsuffocation,respiratoryfailureinducedbyinfectious.diseasesinchildren,andrespiratorydepressionbyCOintoxication.TheNotspecialantagonistsforCNSOverdoseinduceIncreaseoxygenCHAPTERAntiepileptic&AnticonvulsiveDrugsSectionAntiepilepticDrugsEpilepsy癫痫Epilepsyisaheterogeneoussymptomcomplex,achronicdisordercharacterizedbytransitandrecurrentseizurewhichisepisodesofbraindysfunctionresultingfromabnormaldischargeoffocalcerebralneuronanddiffusiontonormalneuronaltissues.Somatic,sensory,automaticandpsychoticsymptoms.Etiology:incidence0.5%-1%.PrimaryepilepsySecondaryepilepsySymptomsandEEGClassificationsofepilepsyPartialseizuresSimplepartialseizuresSomaticseizures运动性发作Sensoryseizures感觉性发作Automaticseizures植物神经性发作Psychoticseizures精神性发作ComplexpartialseizuresPsychomoticseizuresSensoryseizuressecondarilysimpleseizure继发于单纯部分性发作的意识Generalizedseizures(1)Generalizedtonic-clonicseizures(gradmal):强直-阵挛性发作(大发作(2)Absenceseizures(petitmal):失神发作(小发作(3)Tonicseizures:强直发作(4)Myoclonicseizures:阵挛发作(5)AtonicseizuresStatusepilepticus:AtypicalInfantilspasm:ExperimentalmodelsFocusseizuremodels:Co,All,Electricstimulate(alelectroshockseizure,MES):gradPentylenetetrazol(PTZ):absenceHistoryofAntiepilepticDrugs1857potassiumbromide191235ogsofphenobarbital1938phenytoinDevelopmentinthepast4decades:valproate(64),Antiepilepsrin(75)Carbamazepin(80),TheClassificationsofantiepilepticsAnticonvulsivebarbituratesNewActionMechanismsofAntiepilepticToabolishorattenuatetheseizurediffusionbymodificationofionchannelinhibitdischargeininhibitdiffusioninnormalneuron:inhibitoryofNa+andCa2+ToaffectinhibitorysysteminvolvingGABA-ergicEnhancementofGABA-ergicDirectactionontheGABA-R-chloridechannelActionsonthereuptakeormetabolismofDiminutionofglutaminergicAMPA-RblockadeNMDA-RPhenytoinSodium(Dilantin,大仑丁MechanismsofPromotethestablizationoftheBlockvoltage-sensitiveNa+channel(use-dependenteffect)andblockCa2+channel,inhibitPotentiateGABAinhibitingfunction.ClinicalUsesEpilepsy:drugchoiceforgeneralizedtonic-clonicseizures,simplepartialseizuresandcomplexpartialseizuresexceptabsenceseizure.Centralpainsyndrome:neuralgias,trigeminalAbsorptionpKa8.3,slowandunpredictableafteroraladministration,Fvariable,tmaxaround3-12hrs,Css5-7d,stimulationbyoralandim.DistributionPPBR90%,Vd0.6-Metabolismbyhepatomicroenzymesabout60%-70%,5%Eliminationisdose-dependent,smaconcentrationlessthan10g/mL,FOK,6-24hrs,morethan10g/mL,OOK,t1/220-60hrs.AdverseReactionsAdversereactionrelatedtodrugsmaconcentration.Cmax(E)10g/mL;CTox20g/mLGastrointestinalGingivalhypersiabyinhibitingthetheinductionofcollagenasebyCNSsymptoms20g/mL,﹥40g/mL:psychotic,﹥50g/mL:Bloodsystem:leukopenia,agranulocytosis,megalblasticanemia,asticanemia:folicaciddyefficacy.Bonesystemand togenesis,(fetalhydantoinsyndrome)arrhythmia,andhypotension.DrugIn Hepatomicrosomalenzymeinducer:Glucocorticoids,carbamazepine,vitaminBroad–spectrumantiepilepticagentinhibitNa+potentiateGABAinhibitoryfunction.ActionsandUsesAntiepilepticeffectsgradmal,partialseizureswithcomplexsymptomatology,maniaandCentralalgesia:trigeminalneuralgiamoreeffectivethanphenytoin.Tmaxaround2-6hrs,PPBR80%,activecyclooxidemetabolite,t1/235hrsatbeginning,thenmayshortenby50%duetoenzymeinducer.AdverseCNSreactions:drowsness,verigo,nause,vomit,Bloodsystem:leukopenia,agranulocytosis,thrombocytopenia,asticGastrointestinalPhenobarbital(比妥Broad-spectrumandmucheffectiveingradMalandpartialseizures,butnotdrugchoiceforgradmal,alternativeandivinthetreatmentofstatusepilepticus。IncreasethethresholdandinhibitthespreadofseizuretonormaltissuePotentiatetheGABAinhibitoryfunction:pre-synapticGABA-REffectiveforalltypesofepilepsiesexceptabsencemal,moreeffectivethanphenobarbitalincomplexpartialseizures.MechanismsimilartophenobarbitalandNa+in,Primidoneismetabolizedtophenobarbitalandphenylethylmalonamides(PEMA,二酰胺asactivemetabolites.AdverseReactions depression,ataxia,drowsness,Blood thrombocytopenia,megalblasticTheonlyindication:absenceepilepsy.ReducingtheT-typeCa2+currentInhibitingGABAaminotransferaseAdverseReactionsGastricdistress,CNSdistress,bloodsystemleukopenia,thrombocytopenia,megalblasticSodiumValproate(丙戊酸钠,Valproicacid,sodiumdipropylacetate,DPA)Broad–spectrumantiepilepticagent,Effectiveforalltypesofepilepsy,moreeffectivethanethosuxide,lesseffectiveforgradmalandpartialmal.PotentiateGABAfunctionbyinhibitingGABA-aminotransferas(GABA-T)andsuccinicsemialdehydedehydrogenase(SSADH).inhibitvoltage-dependentNa+andL-Ca2+channel.AdverseReactionsHepaticCNSandbloodsystemDiazepamdrugchoiceforstatusepilepticusbyClonazepamandclobazam:absenceseizure,atonicandakineticNitrazepam:myoclonicseizure,atypicalabsenceseizureandinfantileOtherNewDrugsUsedasanadjunctagainstpartialseizuressuchascomplexpartialseizure,mechanismLamotrigine(三嗪Usedasanadd-ontherapyormonotherapyinthetreatmentofabsenceormyoclonicseizureinchildren.Themechanismmayberelatedtoinhibitvoltage-dependentNa+Usedinthetreatmentofpartialseizurewithorwithoutgeneralizedtonic-clonicGeneralprinciplesanddrugchoiceforthetherapyofAccurateThedrugchoiceforinitialtreatmentofgradmalandsimplepartialseizures:carbamazepine,phenytoinforgradmalphenobarbital,primidoneandvalproicacidasalternative.Absenceseizure:ethosuxide,valproicacid,Complexpartialseizures:carbamazepine,phenytoin,promidone,valproicStatusepilepticus:Diazepamiv,clonazepam,phenytoinandTonicseizure:valproicMyoclonicseizure:glucocorticoids,Durationoftherapy:2-3Changedrugoraddaseconddrugand/orWithdrawnordiscontinue---gradually(halfMonitoringtheserumdrugSection2Barbiturates,benzodiazepines,chloralhydrate.MagnesiumSulfateActionsandRelaxantofskeletalmuscleandCNSdepressionbyivorim:anticonvulsant.mechanismduetocalciumantagonism.usedinconvulsioncausedbyeclampsia,respiratoryinhibitionandhypotensionwhenCHAPTERDRUGSUSEDINTHETREATMENTOFCENTRALNERVOUSSYSTEMDEGENRATINGDISORDERSParkinson’sdiseaseFeatures(paralysisagitants):Tremor,rigidity,akinesiaandbradykinesia(ataxia).Pathogenesis(dopamineNigro-striatal(caudatenucleus,putamenandpallidum).DAneuronsdegenerationDopaminergicneuronsactivity↓Cholinergicneuronsactivity↑OxidativestresstheorySectionOneDopaminomimeticDrugsLevodopa(左旋多巴Levodopacouldpenetratesintothebrain,whereitisdecarboxylatedtodopamine.AbsorptionReadyfromsmallintestine,tmax0.5-2hrs,affectedbygastricemptying,gastricacidandaminoacids.DistributionandAbout1%throughbloodbrainbarrierbydopadecarboxylasetodopamine,99%peripheraltransforetodopamine,alittletomelonnin,mostmetabolizedbyCOMTandMAO.Eliminationkidney,t1/21-3hrs.PharmacologicalActionsandUsesLevodopaiswidelyusedfortreatmentofalltypeofparkinsonismexceptthatassociatedwithantipsychoticdrugtherapy.MosteffectiveformildandyoungerMoreeffectiveforrigidityandakinesia,lesseffectiveforOnsetslow,2-3wkstoeffect,1-6monthstoNoeffectiveforParkinson’ssyndromecausedbyHepaticLevodopametabolizedtoadrenalinetoreceoctopamine(falseneurotransmittertheory).AdverseReactionsGastrointestinalCardiovascularAbnormalinvoluntarymovement“on-off”PsychicdisordersandOtherDecarboxylaseCarbidopa(多巴)andbenserazide(苄丝肼)CompoundPreparation:Sinemet(息宁): Levodopa:Carbidopa(10:1) Levodopa:Benserazide(4:1)Mechanismof↑releaseDAfromdopaminegic↓reuptakeofdopaminereceptoragonismClinicalUsesParkinson’sdisease,lesseffectivethanlevodopa,andmoreeffectivethananticholinergicagents.EffectiveforParkinson’ssyndromecausedbyphenothiazines,synergizedbyl-dopa.Onsetrapidly,2wks;Lastshortabout4-8wks.AdverseLivedoPsychoticBromocriptine(溴隐亭andPergolide(培高利特LargedosestimulateD2receptorinsubstantianigro-SmalldosestimulateD2receptorintuberoinfundibular,reducePRLandGHrelease treatPDandhyperprolactinemia.MAO-Binhibitorand

BlockingtheM-R,↓cholinergicneuronsinthebasalBenzatropine(苯扎托品andtrihexyphenidyl(苯海索)ImprovethetremorandrigidityofPD,littleeffectonbradykinesiaDrugTherapyinAlzheimer’sDiseaseAlzheimer’sdisease(AD)1/2,vasculardementia(VD)1/4>65y,3.0%5.0%;6570y,3.0%;7584y,19%;>85y,47%. CourseofADisabout320yInternationalSymposiumforAlzheimer’sDisease2000:“IftheeffectivemethodsforADtreatmentisnotfound,theADpatientswillbe22000000in2025;45000000in2050inwholeClinicalMentia,cognitiondysufficiency,behavioraldisorder.PathologicalFeatures que(SP,老年斑)wasfoundinbrain,neurofibrillarytangles(,神经元纤维缠结)andselectivedeathofneronNeurontoxicationofamyloidβ-protein(Aββ-AβAChEAβTherapyforPotentiatecholinergic AChEI、M-RPotentiatorofneuronalnutritionfactorandneuroncellgrowthActivatorbrainmetabolismDrugsimprovingmicrocirculation麦角类衍生物、都可喜等Calcium

Subjectiveexperienceproducedbyexternalstimulas“psychicaladjuvantofanimperativeprotectivereflex”.PerceptionofpainReactiontopainAcutepain(sharppain),superficialpain,quickresponseofsuddenonset,conductedbyAnervefibers.Chronicpain(dullpain),morelingeringandaching,conductedbyCnerve Drugstorelieveseverepainandfeelingreactionsbypainwithoutaffectingothersenseperception,andconsciousness.SyntheticcompoundsAdditionalCharacteristics:①Potent NarcoticAddictiongesics Opium

Section morphine,codeineBenzylisoquimolinespapaverineSourceandChemistryPapaversomniferum

Morphine(AbsorptionreadyfromGItractbutfirstpasseliminationinliver,sc,imabsorbedwell,distributionnospecialaffinityforbrain,distributedthroughoutofthebody. demeththylation,20% Mainlybyglomerularfiltration,afewbymilkandbile.t1/22.5-3.5hrs.PharmacologicalActionsCNSStrongerandMoreeffectiveincontinuousdullpainthansharpintermittentEuphoria:painstillpresent,butthepatientfeelmoreSedationdrowiness,cloudingofmentation,impairmentofreasoningRespiratory↓RespiratorycenteronthebrainstemtoincreaseinCO2Dose-related,mostdeathfrommorphinepoisonduetorespiratoryAntitussive TodepressthecoughreflexoncoughcenterinOthereffects:miosisduetoexcitatoryactiononthesegmentofnucleusofoculomotornevernauseaandvomitingduetostimulatingofCTZ.SM GI:gastricsecretionandmotilitydecreased,emptyingsmallintestinerestingtoneincrease,propulsiveperistalicwavelargeintestinepassagedelay,waterCNSBiliarytract:biliarycolicbyOddiconstrict.Urinary:Urinationdifficultandurinaryretention.Bronchia:bronchiasthma2.CardiovascularDirectvesseldilatationandinducereleasingofhistamineresultinperipheralreduction,BP↓orhypotension.IncreasecerebrospinalfluidpressureduetoCO2retention,↓Respiration,CO2↑cerebralvasodilationandincreaseintracranialpressureMechanismsofActionThegesicsiteofLaminaeIIIofperiventricularandperiaqueductalgraymaterbypharmacologistsinOpioidreceptorsfoundinearly70’,andsuccessfulclonedbyforeignscientistsinEndogenousopioid peptidefoundEnkephalines:M-orL-enkephelineendorphines:β-endorphine dynorphineAFourmajoropioid(mu): gesia,respiratoryinhibition,euphoria,miosis,physical(kappa): gesia,sedationand(delta): gesia,repiratorydepression,euphoria,physical gesia,dysphoria,hallucination,cardiacinhibition,1,2, OpioidreceptorsrelatedOpioidreceptorsatthalamic,laminaeI,II,III(substantiagalatinosa)ofspinalcordandperiventricularandperiaqueductalgraymatter:intergretion,perception,reactionandOpioidreceptorsatlimbicsystemincludinglocusceruleus,anteriortemporalandorbitalfrontalcortexpartsofhypothalamusandamydala:involvesemotion,psychitricactivity,mayberelatedtoeuphoria,toleranceanddependence.OpioidreceptorsatnucleussolitariusisthelocationofcoughTheareapostremaisthechemoceptortriggerzoneerningnauseaandSubstancePandendogenousgesicsystemClinicalUsesModeratetoseverepain,painofterminalillness,postoperationpain,anginaCardiacDilatingtheperipheralvesseltoreducethePre-andpostloadofRespiratoryConstipationeffecttotreatacuteorchronicdiarrhea.AdverseDrugReactionsSideRespiratorydepression,nausea,vomiting,dizziness,mentalclouding,constipation,biliaryspasm,urinationdifficulty.Tolerance,dependence,addictionandliabilityforabuse.DrugDependencePsychicdependence用药后使人产生一种对药物欣的渴求,这种精神上不能的强烈欲Physicaldependence者一旦停药,将发生一系列生理功能紊乱,称戒断症状(abstinencesyndrome)。Addiction:Drugabuse:Euphoriaaddictionstopuseabstinencesyndromecompulsivedrug-seekingbehavior.Abstinencesyndrome:diarrhea,vomiting,chillsfever,lacrimation,rhinorrhea,tremor,abdominalcrampsandpain.NarcoticsfromGreekword“AdministrationLawforNarcotics”byThemechanismsoftoleranceanddependence:mayberelatedtothenegativefeedbackofopioidreceptorsandendogenousopioidpeptides.TheTreatmentofThegoalsofFromdependenttoMaintenanceofnoRealopioidde-addictionde-addictionorcontrolabstinencephysicalandpsychologicalpreventionofrelapse。ThetreatmentofdependenceWithdrawthepatientfromMethadoneClonidineScopolaminePreventionofreuse:Opioidantagonists-PsychologicalandothermethodstoAcuteRespiratoryinhibition,coma,pinepointpupilisthecharacter,bloodpressureandtemperaturedecrease,deathduetorespiratoryparalysis.Treatment:artificialrespiration,O2,opioidreceptorantagonists.Newborn,infant,breastingperiod,productionpain,braininjury,bronchial pulmonaryheartdisease.Codeine可待因The gesia,about1/12ofmorphine,usedinmoderateProtypecentralantitussives,usedforsuppressingSection PethidineMeperidineDOLANTIN,哌替啶,度冷丁)PharmacologicalpropertiesCNSgesia,sedationanddepressionareweakerandshorterthanmorphine.NoantitussiveSmoothmuscleWeakerthanmorphine,noantidiarrhealeffects,mayinducebiliarycolic,Noantagonisteffectofoxytocin.CardiovascularsystemsimilartomorphineClinicalUsesSevereCardiacPremedicationinanesthesiaandartificialhibernation.AdverseReactionsThesideeffectsaresimilartoCNSexcitatorysymptoms:tremor,musclespasm,reflexaugumentationorconvulsion.SomeOtherNarcotic Fentanyl(芬太尼gesiaandrespiratoryinhibition100timesthanmorphine,shortduration(1-2hrs),usedforseverepainandcombinedwithanestheticstodecreasethedoseofanesthetics,orcombinedwithdroperidolasneuroleptgesia.Methadone(Pharmacologicalpropertiessimilartomorphine,gesiaanddurationequaltomorphine,slowtoleranceandaddiction,abstinencelightusedinseverepainandfordetoxificationandformaintenanceofchronicrecingaddict.Withmoderateandagonism,weakerantagonism,usedinchronicseverepain,onethirdgesiaofmorphineandhalfrespiratoryinhibitionofmorphine.Almostnodependence.Tramadol(gesiceffectsthesamedegreeaspentazocine,alsocausePotentgesicdevelopedbyscientists,10000timesgesiaandsevereaddiction.Non-narcoticgesicsRotundin(l-tetrahydropalmtine,FromtraditionalmedicineCorydalisambigua,moderate gesiaandsedation,durationof2-5hrs,usedforchronicdullpain,visceralpain,headacheandmenstrualpain.LongtermusemayinduceextrapyramidalsyndromesTheOpioidReceptorAntagonistsNaloxoneandNaltrexoneCompetitiveantagonizetheμδκreceptorsAntagonizetheopiateAsatoolagentinpharmacological preventrelapse. injection, t1/21.1hr F30%, t1/210hr gesictherapyforpainassociatedcancerThegoalraisedbyWHOin1982“nopainforcancerpatientsuptotheyearofThePublicHealthMinistryof indicated“usingthreestep therapyforcancerpatients”in1991.Three gesiaMildpainaspirin,acetaminophen,indomethacin,Moderatepaincodeine,tramadol,fortanodyn,bucinnazine,ammophenodeine(500+Severepainmorphine,methadone,pethidine,Theprinciplesofgesiaforcancerpatients.BystepByclockByoralIfnecessary,add gesicandantiinflammtorydrugs,non-steroidalanti-infl torydrugs.Aspirin-likedrugs.Classificationindifferentclassesaccordingtotheirchemicalstructuresandtotheselectivityofcyclo-oxygenase(COX).SelectiveCOXNon-selectiveCOXinhibitorsAccordingthechemicalstructure:AnilinepyrazolonsandotherorganicacidsTheyallinhibitthebiosynthesisofprostaglandins(PGs).TheactionsofNSAIDSarerelatedtothearachidonicacid(AA)metabolism.TheDifferentbiologicalActivitiesoftheProductsof Vasodilationhyperalgesiainhibitetaggregation etaggregationandvasoconstriction. Induceinfl tionfeverand painvasodilationandhyperalgesia. Bronchialconstrictionandvasoconstriction.LTs: Allergy,bronchcoconstrictionleukocytotaxisincreasevascularpermeabilityandinduceinfl Thedifferentanti-infl torymechanismofglucocorticoidsandNSAIDs.Glucocorticoids:inhibit NSAIDs:inhibitCOXandreducetheproductionofThePharmacologicalActionsofAntipyreticBodytemperatureMechanism:inhibitsynthesisofPGsintheCNS.TheyonlydecreasethebodytemperatureofthosewhohaveafeverandnoeffectonnormalTheDifferencebetweenNSAIDsandInhibitthethermotacticcenterandmakeitoutofCausethebodytemperaturetoalterwiththeenvironmenttemperature.NotonlydecreasetheBPofthosewhohaveafeverbutthenormalgesicEffectPropertiesofgesiaMild-to-moderateNoaddictionandnoNorespiratoryCauseofpain: insiteoftissueinjuryorinfl tionsomechemicalalgesiogenicsubstancesareproducedandreleasedsuchasbradykininandsoontogetherwithPGs.Bradykinin:causepainthroughstimulatingthealgesireceptorsPG:(1)(2)PG(E1,E2andF2α)alsohavealgesiogeniceffect.Mechanism:inhibitthesynthesisofPGsinperipheryOnlyeffectivetomildtomoderatepain.Non-narcoticandnoeuphoria.Norespiratory tory tionisthedefensivereactiontolesionfactorsoflivetissueshavingvascularTheroleofPGsin CausevasodilatationandtissueCoordinatewithbradykinintocause Mechanismofanti- toryeffectof(a)Reducingbiosynthesisofprostaglandinsby inhibitingCOX.(b)inhibitionoftheexpressionofsomecelladhesionmolecules.(c)Additionalpossiblemechanisms.Inhibitionofleukocytechemotaxis.Downregulationofinterleukin-1Decreasetheproductionofradicalsandsuperoxide.Interferencewithcalcium-mediatedintracellularevents.SymptomaticNSAIDsonlyrelievethemainclinicalsymptoms(erythema,edema,fever,painanddysfunction)ofinfl tion,buthavenoeffectontheautoimmunologicalprocessofrheumaticandrheumatoidarthritis.ComparisonbetweenCOX-1andCOX- : causefeverandlationofetregulationofrenalbloodlationofperipheralNSAIDsinhibitionofCOX-2isthebaseoftheirtherapeuticeffectswhiletheirinhibitionofCOX-1isthereasonoftheiradversereactions.ButthisisnotabsolutetheantithrombosiseffectofaspirinisbasedonitsinhibitionofCOX-1AccordingtotheselectivityofCOXtheyareclassifiedintoselectiveCOX-2inhibitorandnon-selectiveCOXinhibitor.SECTIONNon-selectiveCOXInhibitorsPartISALICYLATES水杨酸类SalicylatesincludeaspirinandsodiumSodiumsalicylateisawillowbarkextractalonghistoryusagefirst edin1763.Severeadversereaction;rarelyused.Aspirin(Acetylsalicylicacid,阿司匹林,乙酰水杨酸)ProcessintheRapidly,Instomachandsmallintestine(mainlyinthelatter),tpeakis0.5~2hrsWidely,almostthroughoutthebody;synovialfluid,cerebrospinalfliud,passcenta.PPBRisHydrolyzedrapidlytoaceticacidandsalicylateby ses,smat1/2=15SalicylatesaremetabolizedbycytochromeP450intheliver,mostoftheproductsareboundtoglycinesfewofthemareboundtoglucuronicacids.Aspirinp.o.<1.0g: first-orderkinetics,t1/2=2~3hrs;Aspirinp.o.≥1.0g: zero-orderkinetics,t1/2=15~30hrs.ThemetabolitesaremainlyexcretedbyLowdose:mostareexcretedintheformofbound,fewintheformofsalicylate.Inlargedose:manyofthemwillbeexcretedintheformofsalicylate.UrinepHhaveastronginfluenceontheexcretionamountofsalicylatefromkidney.AlkalinepH:SAupto85%Acidic SAlowas5%Sowecouldreducethebloodconcentrationofsalicylatethroughalkalizingtheurine.PharmmacologicalEffectsAspirinandsalicylatesinhibitCOX-1andCOX-2 gesic,ant-infl toryandantirheumaticeffectsBoththeantipyreticand gesiceffectsofaspirinarestrongandrapid.Theant-infl toryandantirheumaticeffectare:(1)relativelystronger;(2)oftenusedtothetolerabledose.Inhibitetaggregationandpreventthrombosis ThereverseeffectsbetweenTXA2andPGI2.ThetheoryofinhibitingetaggregationandpreventinglongerinhibitionforCOXinetthanforCOXinvascularPre-systematiccircularacetylizationShortlifeonly8-11daysandnoproteinbiosynthesiscapacitycomparedwithAspirinadministratedinlowdosecanreduceTXA2remarkablybuthavenoapparentinfluenceonPGI2.ClinicalAntipyresisandHeadache,toothache,myalgia,neuralgia,dysmenorrheaandfeverof tionandDiagnosisandtherapyofacuterheumaticfever,rheumaticandrheumatoidarthritistorelievethesymptoms.Ischemiccardiopathyincludingstableandvariantanginapectorisandprogressivemyocardialinfarctionpatients.Itcanreducemortalityandre-ischemia.Intransientischemicattackpatientstopreventcerebralthrombosis.inangiosty,bypasstransntoperationstopreventthrombosisAlzheimer,sdisease(AD):ADisrelatedtotheover-expressionofCOX-2inbrain.Aspirin100mgp.o.dailyhasrepressioneffectonAD.Pregnancy-inducedhypertensionsyndromeandpreeclampsia:isrelatedtotheincreaseoftheratioofTXA2toPGI2inblood.Aspirin40-100mgp.o.dailycanreducetheincidenceofPIHandthedangerofpreeclamapsia.AdverseReactionsGastrointestinal①irritategastricmucosadirectly:causeepigastricdistressnauseaand②irritatechemoreceptortriggerzone(CTZ):causenauseaand③Gastriculcer:ASAcancauseanddeteriorateulcer.TakeitaftermealChewitintoTakeitalongwithTakeentericcoatingtabletscandecreaseorevenavoidaboveadverseBloodCoagulationInusualdose,inhibitetcoagulationandprolongthebleedingInhighdoseorinlongterm,alsoinhibittheformationofprothombinandprolongtheprothombintimevitaminKcanpreventit.Severehepaticdamage,prothrombinopenia,bleedingtendency,vitaminKdeficiency,stopuseoneweekbeforeoperationUrticaria,allergicAspirin-asthma:AsthmainducedbytheadministrationofaspirinorotherNSAIDSinsomeasthmapatients.Itisnotcausedbyallergicreactionbaseonantigen-antibodyCOX:Lipoxygenase:Endogenousbronchoconstrictantdominatecausebronchialspasmandinduceasthma. Adrenalinehasnouseonit,butwecantreatitwithantihistaminesandControundications:nasalpolyp,asthma,chronicurticaria,histroyofWhenthedoseofaspirinistoohigh,≥5mg/d,thepatientsmaysufferfromheadache,dizziness,nausea,vomiting,tinnitus,sightandhearingfailure.Severepatientsmaysufferfromhyperventilation,acid-baseinbalance,evenmentalconfusion,theseareallcalledsalicylism.Treatment:sodiumbicarbonateiv.Reye’sSeverehepaticdysfunctionwithcomplicationofencephalopathy,substituteaspirinwithDrugInCompetethebandingtosma cedicoumarol(双香豆素)enhanceitsanticoagulationeffectevencausehemorrhage. cetolbutamide(甲苯磺丁脲)andcausehypoglycemia. ceglucocorticoids(糖皮质激素)enhanceitsanti-infl toryeffectalsoenhanceitseffectofinducingulcerCompetetheautosecretioncarriersinrenalfurosemid(alkalinedrugsPartIIANLINESAcetaminophenandPhenacetin(对乙酰氨基 非那西丁InhibitthesynthesisofPGinCNSbuthaslittleeffectontheCOXinUsedinusualdosefewadversereactions,ifusedoverdose,itcancausehepaticinjury.Phenacetinitistrans

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论